This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019; 25: 1822–1832.FurmanDCampisiJVerdinECarrera-BastosPTargSFranceschiCFerrucciLGilroyDWFasanoAMillerGWChronic inflammation in the etiology of disease across the life spanNat Med.20192518221832Search in Google Scholar
Gandhi J, Khera L, Gaur N, Paul C, Kaul R. Role of Modulator of Inflammation Cyclooxygenase-2 in gammaherpesvirus mediated tumorigenesis. Front Microbiol. 2017; 8: 538.GandhiJKheraLGaurNPaulCKaulRRole of Modulator of Inflammation Cyclooxygenase-2 in gammaherpesvirus mediated tumorigenesisFront Microbiol.20178538Search in Google Scholar
Linton MF, Fazio S. Cyclooxygenase products and atherosclerosis. Drug Discov Today. Ther. Strateg. 2008; 5: 25–36.LintonMFFazioSCyclooxygenase products and atherosclerosisDrug Discov Today. Ther. Strateg.200852536Search in Google Scholar
Szweda M, Rychlik A, Babińska I, Pomianowski A. Significance of cyclooxygenase-2 in oncogenesis. J Vet Res. 2019; 63: 215–224.SzwedaMRychlikABabińskaIPomianowskiASignificance of cyclooxygenase-2 in oncogenesisJ Vet Res.201963215224Search in Google Scholar
Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler. Thromb Vas Biol. 2011; 31: 986–1000.RicciottiEFitzGeraldGAProstaglandins and inflammationArterioscler. Thromb Vas Biol.2011319861000Search in Google Scholar
St-Louis I, Singh M, Brasseur K, Leblanc V, Parent S, Asselin E. Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroids. Reprod Biol Endocrinol. 2010; 24: 103.St-LouisISinghMBrasseurKLeblancVParentSAsselinEExpression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroidsReprod Biol Endocrinol.201024103Search in Google Scholar
Nunes CDR, Barreto Arantes M, Menezes de Faria Pereira P, Leandro da Cruz L, de Souza Passos M, Pereira de Moraes L, Vieira IJC, Barros de Oliveira D. Plants as sources of anti-Inflammatory agents. Molecules. 2020; 25: 3726.NunesCDRBarreto ArantesMMenezes de Faria PereiraPLeandro da CruzLde Souza PassosMPereira de MoraesLVieiraIJCBarros de OliveiraDPlants as sources of anti-Inflammatory agentsMolecules.2020253726Search in Google Scholar
Ozleyen A, Yilmaz YB, Donmez S, Atalay HN, Antika G, Tumer RB. Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention. J Cancer Res Clin Oncol. 2023; 149: 2095–2113.OzleyenAYilmazYBDonmezSAtalayHNAntikaGTumerRBLooking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and preventionJ Cancer Res Clin Oncol.202314920952113Search in Google Scholar
Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180: 114147.BinduSMazumderSBandyopadhyayUNon-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspectiveBiochem Pharmacol.2020180114147Search in Google Scholar
Becker JC, Domschke W, Pohle T. Current approaches to prevent NSAID-induced gastropathy – COX selectivity and beyond. Br J Clin Pharmacol. 2004; 58: 587–600.BeckerJCDomschkeWPohleTCurrent approaches to prevent NSAID-induced gastropathy – COX selectivity and beyondBr J Clin Pharmacol.200458587600Search in Google Scholar
Walker C. Are all COX-2 selective inhibitors the same? A consideration of celecoxib, etoricoxib, and diclofenac. Int J Rheum. 2018; 2018: 1302835.WalkerCAre all COX-2 selective inhibitors the same? A consideration of celecoxib, etoricoxib, and diclofenacInt J Rheum.201820181302835Search in Google Scholar
Attiq A, Jalil J, Husain K, Ahmad W. Raging the war against inflammation with natural products. Front Pharmacol. 2018; 9: 1–27.AttiqAJalilJHusainKAhmadWRaging the war against inflammation with natural productsFront Pharmacol.20189127Search in Google Scholar
Tabassum H, Ahmad A, Ahmad IZ. Nigella sativa L. and Its Bioactive Constituents as Hepatoprotectant: A Review. Curr Pharm Biotechnol. 2018; 19: 43–67.TabassumHAhmadAAhmadIZNigella sativa L. and Its Bioactive Constituents as Hepatoprotectant: A ReviewCurr Pharm Biotechnol.2018194367Search in Google Scholar
Ben-Arye E, Lev E, Schiff E. Complementary medicine oncology research in the Middle-East: Shifting from traditional to integrative cancer care. Eur J Integr Med. 2011; 3: 29–37.Ben-AryeELevESchiffEComplementary medicine oncology research in the Middle-East: Shifting from traditional to integrative cancer careEur J Integr Med.201132937Search in Google Scholar
Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013; 3: 337–352.AhmadAHusainAMujeebMKhanSANajmiAKSiddiqueNADamanhouriZAAnwarFA review on therapeutic potential of Nigella sativa: A miracle herbAsian Pac J Trop Biomed.20133337352Search in Google Scholar
Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol Res. 2015; 95–96: 138–158.DarakhshanSBidmeshki PourAHosseinzadeh ColagarASisakhtnezhadSThymoquinone and its therapeutic potentialsPharmacol Res.201595–96138158Search in Google Scholar
Tajmiri S, Farhangi MA, Dehghan P. Nigella Sativa treatment and serum concentrations of thyroid hormones, transforming growth factor β (TGF-β) and interleukin 23 (IL-23) in patients with Hashimoto's Thyroiditis. Eur J Integr Med. 2016; 8: 576–580.TajmiriSFarhangiMADehghanPNigella Sativa treatment and serum concentrations of thyroid hormones, transforming growth factor β (TGF-β) and interleukin 23 (IL-23) in patients with Hashimoto's ThyroiditisEur J Integr Med.20168576580Search in Google Scholar
Ijaz H, Tulain UR, Qureshi J, Danish Z, Musayab S, Akhtar MF, Saleem A, Khan KAUR, Zaman M, Waheed I, et al. Nigella sativa (Prophetic Medicine): A Review. Pak. J Pharm Sci. 2017; 30: 229–234.IjazHTulainURQureshiJDanishZMusayabSAkhtarMFSaleemAKhanKAURZamanMWaheedINigella sativa (Prophetic Medicine): A ReviewPak. J Pharm Sci.201730229234Search in Google Scholar
Ali BH, Blunden G. Pharmacological and Toxicological Properties of Eugenol. Phyther Res. 2003; 17: 299–305.AliBHBlundenGPharmacological and Toxicological Properties of EugenolPhyther Res.200317299305Search in Google Scholar
Gawron G, Krzyczkowski W, Lemke K, Ołdak A, Kadziński L, Banecki B. Nigella sativa seed extract applicability in preparations against methicillin-resistant Staphylococcus aureus and effects on human dermal fibroblasts viability. J Ethnopharmacol. 2019; 244: 1–7.GawronGKrzyczkowskiWLemkeKOłdakAKadzińskiLBaneckiBNigella sativa seed extract applicability in preparations against methicillin-resistant Staphylococcus aureus and effects on human dermal fibroblasts viabilityJ Ethnopharmacol.201924417Search in Google Scholar
Joshi RK. Angelica (Angelica glauca and A. archangelica) oils. Elsevier Inc., 2016.JoshiRKAngelica (Angelica glauca and A. archangelica) oilsElsevier Inc.2016Search in Google Scholar
Pavela R, Zabka M, Vrchotova N, Triska J, Kazda J. Selective effects of the extract from Angelica archangelica L. against Harmonia axyridis (Pallas) - An important predator of aphids. Ind Crops Prod. 2013; 51: 87–92.PavelaRZabkaMVrchotovaNTriskaJKazdaJSelective effects of the extract from Angelica archangelica L. against Harmonia axyridis (Pallas) - An important predator of aphidsInd Crops Prod.2013518792Search in Google Scholar
Kumar D, Bhat ZA, Shah MY. Anti-anxiety activity of successive extracts of angelica archangelica linn. on the elevated t-maze and forced swimming tests in rats. J Tradit Chinese Med. 2012; 32: 423–429.KumarDBhatZAShahMYAnti-anxiety activity of successive extracts of angelica archangelica linn. on the elevated t-maze and forced swimming tests in ratsJ Tradit Chinese Med.201232423429Search in Google Scholar
Oliveira CR, Spindola DG, Garcia DM, Erustes A, Bechara A, Palmeira-dos-Santos C, Smaili S, Pereira GJS, Hinsberger A, Viriato EP, et al. Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development. J Integr Med. 2019; 17: 132–140. https://doi.org/10.1016/j.joim.2019.02.001OliveiraCRSpindolaDGGarciaDMErustesABecharaAPalmeira-dos-SantosCSmailiSPereiraGJSHinsbergerAViriatoEPMedicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor developmentJ Integr Med.201917132140https://doi.org/10.1016/j.joim.2019.02.001Search in Google Scholar
Kumar D, Bhat ZA, Kumar V, Shah MY. Coumarins from Angelica archangelica Linn. and their effects on anxiety-like behavior. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013; 40: 180–186.KumarDBhatZAKumarVShahMYCoumarins from Angelica archangelica Linn. and their effects on anxiety-like behaviorProg Neuro-Psychopharmacol Biol Psychiatry.201340180186Search in Google Scholar
Chauhan RS, Nautiyal MC, Cecotti R, Mella M, Tava A. Variation in the essential oil composition of Angelica archangelica from three different altitudes in Western Himalaya. India, Ind Crops Prod. 2016; 94: 401–404.ChauhanRSNautiyalMCCecottiRMellaMTavaAVariation in the essential oil composition of Angelica archangelica from three different altitudes in Western HimalayaIndia, Ind Crops Prod.201694401404Search in Google Scholar
Baranowska M, Koziara Z, Suliborska K, Chrzanowski W, Wormstone M, Namieśnik J, Bartoszek A. Interactions between polyphenolic antioxidants quercetin and naringenin dictate the distinctive redox-related chemical and biological behaviour of their mixtures. Sci Rep. 2021; 11: 12282.BaranowskaMKoziaraZSuliborskaKChrzanowskiWWormstoneMNamieśnikJBartoszekAInteractions between polyphenolic antioxidants quercetin and naringenin dictate the distinctive redox-related chemical and biological behaviour of their mixturesSci Rep.20211112282Search in Google Scholar
El Mezayen R, El Gazzar M, Nicolls MR, Marecki JC, Dreskin SC, Nomiyama H. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett. 2016; 106: 72–81.El MezayenREl GazzarMNicollsMRMareckiJCDreskinSCNomiyamaHEffect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammationImmunol Lett.20161067281Search in Google Scholar
Sevigny AM, Graham K, Ponce E, Louie MC, Mitchell K. Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors. Pharm Res. 2012; 65: 445–450.SevignyAMGrahamKPonceELouieMCMitchellKGlycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitorsPharm Res.201265445450Search in Google Scholar
Li F, Rajendran P, Sethi G. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. Br J Pharmacol. 2010; 161: 541–554.LiFRajendranPSethiGThymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathwayBr J Pharmacol.2010161541554Search in Google Scholar
El-Mahmoudy A, Shimizu Y, Shiina T, Matsuyama H, Nikami H, Takewaki T. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: Effect of thymoquinone. Acta Diabetol. 2005; 42; 23–30.El-MahmoudyAShimizuYShiinaTMatsuyamaHNikamiHTakewakiTMacrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: Effect of thymoquinoneActa Diabetol.2005422330Search in Google Scholar